Prolonged secondary amenorrhoea after oral contraceptive therapy. Natural and unnatural history

Pregnancy in women with Kallmann's syndrome.

Fertility and sterility·1995

Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial.

American journal of reproductive immunology (New York, N.Y. : 1989)·1993

A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.

The Australian & New Zealand journal of obstetrics & gynaecology·1991

Autoimmune oophoritis: a clinicopathologic assessment of 12 cases.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·1990

Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.

The Australian & New Zealand journal of obstetrics & gynaecology·1989

Blepharophimosis plus ovarian failure: a likely candidate for a contiguous gene syndrome.

Journal of medical genetics·1989

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Attitude and acceptability of IVF add-ons to improve reproductive outcomes: a focus group qualitative study.

Human reproduction (Oxford, England)·2026

In Vitro Fertilization or Intrauterine Insemination in Unexplained Infertility.

The New England journal of medicine·2026

Chromosomal aberrations of reproductive dysfunction: An in-depth retrospective study of 1943 individuals with unexplained infertility.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Ventricular False Tendons and Ventricular Arrhythmias: Distinguishing Incidental Findings From Culprit Substrates.

Pacing and clinical electrophysiology : PACE·2026

Access to abortion and subsequent fertility preferences and reproductive outcomes in Nepal (2019-2024): a prospective cohort study.

The Lancet regional health. Southeast Asia·2026

Antioxidants in male infertility: from empirical supplementation to phenotype directed therapy.

Frontiers in endocrinology·2026

Prolonged secondary amenorrhoea after oral contraceptive therapy. Natural and unnatural history

Related Experiment Videos

Related Concept Videos

Pregnancy in women with Kallmann's syndrome.

Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial.

A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.

Autoimmune oophoritis: a clinicopathologic assessment of 12 cases.

Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.

Blepharophimosis plus ovarian failure: a likely candidate for a contiguous gene syndrome.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Attitude and acceptability of IVF add-ons to improve reproductive outcomes: a focus group qualitative study.

In Vitro Fertilization or Intrauterine Insemination in Unexplained Infertility.

Chromosomal aberrations of reproductive dysfunction: An in-depth retrospective study of 1943 individuals with unexplained infertility.

Ventricular False Tendons and Ventricular Arrhythmias: Distinguishing Incidental Findings From Culprit Substrates.

Access to abortion and subsequent fertility preferences and reproductive outcomes in Nepal (2019-2024): a prospective cohort study.

Antioxidants in male infertility: from empirical supplementation to phenotype directed therapy.

Prolonged secondary amenorrhoea after oral contraceptive therapy. Natural and unnatural history

Related Experiment Videos

Related Concept Videos

Related Articles